Table 1.
Characteristics of subjects at baseline.
| Characteristic | Treatment group | ||
|---|---|---|---|
| Diclofenac | Wobenzym | Placebo | |
| Gender (% female) |
76.1 | 67.3 | 76.9 |
| Age (years) | 63.5 (47–80)1 | 61 (47–80) | 61.5 (44–81) |
| Body weight (kg) | 79.5 (60–107) | 79.5 (55–127) | 78.0 (48–132) |
| Height (cm) | 166 (150–183) | 165 (147–193) | 165 (150–185) |
| Body mass index | 28.4 (21.5–44.3) | 28.2 (21.7–37.9) | 27.5 (16.2–44.4) |
|
| |||
| Months since initial diagnosis of knee osteoarthritis | |||
| 55 (<1–261) | 43.5 (1–397) | 47.5 (2–417) | |
|
| |||
| Duration of currently active symptoms (months) | |||
| 3 (<1–245) | 6 (<1–255) | 5.5 (1–159) | |
1All values presented as medians (range).